Guofang C. Hou
State Key Laboratory Of Systems Medicine For Cancer
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs.
Journal: Nucleic acids research
Published: June 24, 2024
IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth.
Journal: Cell reports
Published: January 02, 2024
RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth.
Journal: Nature structural & molecular biology
Published: October 17, 2023
Clinical efficacy of a modified no-touch technique in the establishment of autologous arteriovenous fistula
Journal: Zhonghua yi xue za zhi
Published: March 08, 2023
The negative effect of G1958A polymorphism on MTHFD1 protein stability and HCC growth.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 28, 2023
IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia.
Journal: Nature communications
Published: January 10, 2023
SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Journal: Nucleic acids research
Published: September 19, 2020
SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function.
Journal: Nucleic acids research
Published: January 25, 2018
SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis.
Journal: Molecular cancer
Published: May 23, 2017
miR186 suppresses prostate cancer progression by targeting Twist1.
Journal: Oncotarget
Published: November 22, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026